Total Payments
$14,051
2024 Payments
$200.00
Companies
7
Transactions
29
Medicare Patients
602
Medicare Billing
$79,722
Payment Breakdown by Category
Consulting$4,925 (35.1%)
Other$4,305 (30.6%)
Travel$4,013 (28.6%)
Food & Beverage$807.95 (5.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $4,925 | 3 | 35.1% |
| Travel and Lodging | $4,013 | 9 | 28.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,305 | 3 | 16.4% |
| Honoraria | $2,000 | 1 | 14.2% |
| Food and Beverage | $807.95 | 13 | 5.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eisai Inc. | $5,166 | 8 | $0 (2018) |
| Exelixis Inc. | $3,797 | 13 | $0 (2021) |
| Jubilant DraxImage Inc. | $3,738 | 3 | $0 (2017) |
| Bayer Healthcare Pharmaceuticals Inc. | $880.00 | 1 | $0 (2023) |
| GENZYME CORPORATION | $325.00 | 2 | $0 (2024) |
| Shire North American Group Inc | $125.00 | 1 | $0 (2017) |
| Beckman Coulter, Inc. | $19.97 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $200.00 | 1 | GENZYME CORPORATION ($200.00) |
| 2023 | $880.00 | 1 | Bayer Healthcare Pharmaceuticals Inc. ($880.00) |
| 2022 | $125.00 | 1 | GENZYME CORPORATION ($125.00) |
| 2021 | $1,980 | 1 | Exelixis Inc. ($1,980) |
| 2019 | $1,817 | 12 | Exelixis Inc. ($1,817) |
| 2018 | $5,186 | 9 | Eisai Inc. ($5,166) |
| 2017 | $3,863 | 4 | Jubilant DraxImage Inc. ($3,738) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/12/2024 | GENZYME CORPORATION | CAPRELSA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $200.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 03/20/2023 | Bayer Healthcare Pharmaceuticals Inc. | Vitrakvi (Drug) | Consulting Fee | Cash or cash equivalent | $880.00 | General |
| Category: Oncology | ||||||
| 03/15/2022 | GENZYME CORPORATION | CAPRELSA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $125.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/16/2021 | Exelixis Inc. | CABOMETYX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,980.00 | General |
| Category: Oncology | ||||||
| 11/12/2019 | Exelixis Inc. | — | Food and Beverage | In-kind items and services | $134.37 | General |
| 04/12/2019 | Exelixis Inc. | — | Travel and Lodging | In-kind items and services | $141.57 | General |
| 04/12/2019 | Exelixis Inc. | — | Food and Beverage | In-kind items and services | $61.20 | General |
| 04/12/2019 | Exelixis Inc. | — | Food and Beverage | In-kind items and services | $40.72 | General |
| 04/12/2019 | Exelixis Inc. | — | Food and Beverage | In-kind items and services | $35.35 | General |
| 04/12/2019 | Exelixis Inc. | — | Food and Beverage | In-kind items and services | $29.92 | General |
| 04/12/2019 | Exelixis Inc. | — | Food and Beverage | In-kind items and services | $29.92 | General |
| 04/12/2019 | Exelixis Inc. | — | Travel and Lodging | In-kind items and services | $25.00 | General |
| 04/11/2019 | Exelixis Inc. | — | Travel and Lodging | In-kind items and services | $727.04 | General |
| 04/11/2019 | Exelixis Inc. | — | Travel and Lodging | In-kind items and services | $323.76 | General |
| 04/11/2019 | Exelixis Inc. | — | Travel and Lodging | In-kind items and services | $141.57 | General |
| 04/11/2019 | Exelixis Inc. | — | Food and Beverage | In-kind items and services | $126.54 | General |
| 04/24/2018 | Eisai Inc. | Lenvima (Drug) | Consulting Fee | Cash or cash equivalent | $3,920.00 | General |
| Category: Oncology | ||||||
| 04/24/2018 | EISAI INC. | Lenvima (Drug) | Travel and Lodging | Cash or cash equivalent | $778.59 | General |
| Category: Oncology | ||||||
| 04/24/2018 | EISAI INC. | Lenvima (Drug) | Travel and Lodging | Cash or cash equivalent | $292.67 | General |
| Category: Oncology | ||||||
| 04/24/2018 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $124.98 | General |
| Category: Oncology | ||||||
| 04/24/2018 | EISAI INC. | Lenvima (Drug) | Travel and Lodging | Cash or cash equivalent | $21.00 | General |
| Category: Oncology | ||||||
| 04/24/2018 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $15.99 | General |
| Category: Oncology | ||||||
| 04/24/2018 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $9.53 | General |
| Category: Oncology | ||||||
| 04/24/2018 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $2.99 | General |
| Category: Oncology | ||||||
| 02/13/2018 | Beckman Coulter, Inc. | CYTOFLEX (Device) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: FLOW CYTOMETRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 119 | 165 | $47,853 | $15,672 |
| 2022 | 1 | 169 | 237 | $72,285 | $23,683 |
| 2021 | 3 | 191 | 292 | $76,570 | $24,786 |
| 2020 | 2 | 123 | 186 | $58,998 | $15,581 |
Total Patients
602
Total Services
880
Medicare Billing
$79,722
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 119 | 165 | $47,853 | $15,672 | 32.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 169 | 237 | $72,285 | $23,683 | 32.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 152 | 210 | $64,374 | $21,325 | 33.1% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2021 | 27 | 70 | $6,720 | $1,743 | 25.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 12 | 12 | $5,476 | $1,719 | 31.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 110 | 173 | $52,927 | $13,916 | 26.3% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 13 | 13 | $6,071 | $1,665 | 27.4% |
About Dr. Kenneth Ain, MD
Dr. Kenneth Ain, MD is a Internal Medicine healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396857173.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Ain, MD has received a total of $14,051 in payments from pharmaceutical and medical device companies, with $200.00 received in 2024. These payments were reported across 29 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($4,925).
As a Medicare-enrolled provider, Ain has provided services to 602 Medicare beneficiaries, totaling 880 services with total Medicare billing of $79,722. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Diabetes & Metabolism
- Location Lexington, KY
- Active Since 08/31/2006
- Last Updated 04/30/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1396857173
Products in Payments
- Lenvima (Drug) $5,166
- HICON I-131 Sodium Iodide Solution (Drug) $3,738
- CABOMETYX (Drug) $1,980
- Vitrakvi (Drug) $880.00
- CAPRELSA (Drug) $325.00
- NATPARA (Drug) $125.00
- CYTOFLEX (Device) $19.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lexington
Dr. Firas Badin, M.d, M.D
Internal Medicine — Payments: $1.9M
Internal Medicine $1.9M
Dennis Doherty, Md, MD
Internal Medicine — Payments: $686,622
Internal Medicine $686,622
Dr. Robert Sawyer, M.d, M.D
Internal Medicine — Payments: $232,104
Internal Medicine $232,104
David Mannino, Md, MD
Internal Medicine — Payments: $140,029
Internal Medicine $140,029
Dr. Anastasia Jandes, Md, MD
Internal Medicine — Payments: $90,742
Internal Medicine $90,742
Gloria Vigliani, M.d, M.D
Internal Medicine — Payments: $89,452
Internal Medicine $89,452